Benjamin Primack
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
- Oncology 4
- PARP inhibition in cancer therapy 2
- CAR-T cell therapy research 1
- Cancer-related Molecular Pathways 1
-
- DNA Repair Mechanisms 4
- CRISPR and Genetic Engineering 1
- Co-authors
- Alan D. D’Andrea (3 shared papers)Jessie Liu (1 shared paper)Panagiotis A. Konstantinopoulos (1 shared paper)Simon J. Boulton (1 shared paper)Ildikó Hajdú (1 shared paper)Raphaël Ceccaldi (1 shared paper)Mark I.R. Petalcorin (1 shared paper)Kevin W. O’Connor (1 shared paper)
- Journals
- Cell Reports (1 paper)Nature (1 paper)Molecular Cell (1 paper)Molecular and Cellular Biology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Benjamin Primack
7 papers receiving 1.0k citations
Benjamin Primack's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 557
- Molecular Biology 806
- Cancer Research 121
- Reproductive Medicine 41
- Genetics 111
Countries citing papers authored by Benjamin Primack
This map shows the geographic impact of Benjamin Primack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Primack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Primack more than expected).
Fields of papers citing papers by Benjamin Primack
This network shows the impact of papers produced by Benjamin Primack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Primack. The network helps show where Benjamin Primack may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Primack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair Hit paper breakdown → | 2015 | 735 |
| 2 | 2016 | 225 | |
| 3 | 2013 | 54 | |
| 4 | 2013 | 33 | |
| 5 | 2025 | 7 | |
| 6 | 2025 | 4 | |
| 7 | 2014 | 1 |
About Benjamin Primack
Benjamin Primack is a scholar working on Oncology, Molecular Biology, Immunology and Allergy, Pulmonary and Respiratory Medicine and Immunology, having authored 7 papers that have together received 1.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), PARP inhibition in cancer therapy (2 papers), Advanced Breast Cancer Therapies (2 papers), CRISPR and Genetic Engineering (1 paper), Cell Adhesion Molecules Research (1 paper), Galectins and Cancer Biology (1 paper), CAR-T cell therapy research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (557 citations), Molecular Biology (806 citations), Cancer Research (121 citations), Reproductive Medicine (41 citations) and Genetics (111 citations). Benjamin Primack has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Alan D. D’Andrea, Jessie Liu, Panagiotis A. Konstantinopoulos, Simon J. Boulton, Ildikó Hajdú, Raphaël Ceccaldi, Mark I.R. Petalcorin, Kevin W. O’Connor, Stephen J. Elledge and Ravindra Amunugama. Their work appears in journals such as Cell Reports, Nature, Molecular Cell, Molecular and Cellular Biology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.